Alligator Bioscience AB (publ) (STO:ATORX)
0.0476
-0.0028 (-5.56%)
Jul 24, 2026, 5:29 PM CET
Alligator Bioscience AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 32.98 | 62.2 | 64.31 | 66.12 | 97.31 | 278.15 |
Cash & Short-Term Investments | 32.98 | 62.2 | 64.31 | 66.12 | 97.31 | 278.15 |
Cash Growth | 14.31% | -3.28% | -2.73% | -32.05% | -65.02% | 169.15% |
Accounts Receivable | - | - | 0.52 | 0 | 13.93 | 7.45 |
Other Receivables | 3.72 | 3.71 | 3.84 | 4.52 | 3.64 | 7.04 |
Total Trade Receivables | 3.72 | 3.71 | 4.36 | 4.52 | 17.57 | 14.49 |
Other Current Assets | 16.65 | 2.75 | 2.73 | 7.55 | 7.94 | 6.98 |
Total Current Assets | 53.36 | 68.66 | 71.4 | 78.19 | 122.81 | 299.61 |
Net Property, Plant & Equipment | 1.6 | 1.87 | 3.02 | 20.31 | 26.94 | 15.42 |
Other Intangible Assets | 40.07 | 40.07 | 27.87 | 17.96 | 18.02 | 18.17 |
Other Long-Term Assets | - | - | 2.06 | 1.99 | 1.82 | - |
Total Assets | 95.02 | 110.6 | 104.34 | 118.45 | 169.58 | 333.2 |
Accounts Payable | 4.46 | 4.58 | 3.95 | 21.27 | 13.34 | 9.37 |
Accrued Expenses | 11.04 | 28.32 | 46.76 | 65.96 | 39.66 | 29.59 |
Current Portion of Leases | 9 | 9.21 | 10.1 | 8.58 | 8.5 | 6.23 |
Other Current Liabilities | 5.86 | 36.04 | 140.64 | 3.26 | 3.03 | 2.24 |
Total Current Liabilities | 30.36 | 78.15 | 201.45 | 99.08 | 64.53 | 47.42 |
Long-Term Leases | 23.38 | 25.6 | 33.48 | 7.52 | 16 | 3.51 |
Total Long-Term Liabilities | 23.38 | 25.6 | 33.48 | 7.52 | 16 | 3.51 |
Total Liabilities | 53.75 | 103.74 | 234.93 | 106.6 | 80.53 | 50.93 |
Common Stock | 125.62 | 8.76 | 0.61 | 42.17 | 88.61 | 88.23 |
Additional Paid-in Capital | 1,213 | 1,301 | 1,147 | 1,055 | 911.9 | 911.83 |
Retained Earnings | -1,298 | -1,303 | -1,278 | -1,086 | -911.46 | -717.79 |
Shareholders' Equity | 41.28 | 6.86 | -130.59 | 11.86 | 89.05 | 282.27 |
Total Liabilities & Equity | 95.02 | 110.6 | 104.34 | 118.45 | 169.58 | 333.2 |
Total Debt | 32.38 | 34.81 | 43.57 | 16.1 | 24.5 | 9.74 |
Net Cash (Debt) | 0.6 | 27.39 | 20.74 | 50.02 | 72.8 | 268.41 |
Net Cash Growth | -97.82% | 32.08% | -58.54% | -31.29% | -72.88% | 194.09% |
Net Cash Per Share | 0.00 | 0.99 | 28.24 | 111.53 | 330.05 | 2993.33 |
Book Value | 41.28 | 6.86 | -130.59 | 11.86 | 89.05 | 282.27 |
Book Value Per Share | 0.26 | 0.25 | -177.84 | 26.43 | 403.70 | 3147.91 |
Tangible Book Value | 1.21 | -33.21 | -158.45 | -6.11 | 71.03 | 264.11 |
Tangible Book Value Per Share | 0.01 | -1.21 | -215.79 | -13.62 | 322.02 | 2945.31 |